The Peter Attia Drive

Snapshot · The Peter Attia Drive

#401 ‒ How curiosity transforms medicine: extraordinary discoveries that changed modern healthcare

Explore episode Jul 27, 2026

Where this was said

From snake venom to ACE inhibitors: the discovery of a cornerstone therapy for cardiovascular disease

At 25:00 · chapter starts 21:00

The story begins in Brazil in the 1940s, where pharmacologist Maurício Rocha e Silva was testing the hypothesis that pit viper venom caused circulatory shock by releasing histamine from blood plasma. The hypothesis was wrong. The venom released something else entirely: a potent vasodilating peptide he named bradykinin. A decade and a half later, Rocha e Silva's graduate student Sérgio Ferreira noticed that bradykinin in plasma was more active than synthetic bradykinin, and traced the discrepancy to a second family of venom peptides — Bradykinin Potentiating Factors (BPFs) — that protected bradykinin from degradation. Ferreira carried powdered BPF to London, to a lab studying pulmonary circulation, where postdoc Kevin Ng had discovered that angiotensin I converts to angiotensin II in the lungs. A key convergence: the same enzyme that destroyed bradykinin was also making angiotensin II — a dual-function regulator sitting at the center of the blood pressure system. Squibb's chemists used the smallest active BPF peptide as a structural lead and designed captopril, the first oral ACE inhibitor, approved by the FDA in 1981. From captopril came enalapril, lisinopril, ramipril, and ultimately the angiotensin receptor blockers. The renin-angiotensin-aldosterone system is now one of the most drugged pathways in medicine. The causal chain from a Brazilian snake farm to tens of millions of lives saved spans 70 years and five countries — and nobody in it set out to treat hypertension.

Health & Fitness
The Causal Chain from Bradykinin to Captopril

#401 ‒ How curiosity transforms medicine: extraordinary dis… · Jul 27, 2026 Health & Fitness

Maurício Rocha e Silva wasn't looking for bradykinin — he was testing a wrong hypothesis about histamine and circulatory shock. The accidental discovery of bradykinin, then of BPF, then of ACE's dual role in blood pressure, handed medicinal chemists a structural lead for captopril that no one had designed from first principles.

Science
Taq Polymerase: How a Yellowstone Hot Spring Made PCR Possible

#401 ‒ How curiosity transforms medicine: extraordinary dis… · Jul 27, 2026 Science

PCR was conceptually brilliant but practically useless until scientists needed a polymerase that could survive being heated to 95°C cycle after cycle. That enzyme had been sitting in public culture collections since 1969, isolated from a Yellowstone hot spring by a microbiologist who just wanted to know if life could exist at near-boiling temperatures.

Similar snapshots

Health & Fitness
Pipe broke → hydrogen sulfide studio air

Tortilla Face · Aug 10, 2026

A broken pipe filled the Bad Friends studio with what the hosts identified as hydrogen sulfide — microscopic fecal aeroparticles — that the crew denied smelling.